Drug Type Stem cell therapy |
Synonyms BE ABE8e-SpRY |
Target |
Mechanism CYBB modulators(Cytochrome b-245 heavy chain modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseSuspendedPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Granulomatous Disease, Chronic | Phase 2 | US | 17 Apr 2024 |